Cargando…

A novel imidazolinone metformin‐methylglyoxal metabolite promotes endothelial cell angiogenesis via the eNOS/HIF‐1α pathway

Peripheral arterial disease (PAD) is one of the major complications of diabetes due to an impairment in angiogenesis. Since there is currently no drug with satisfactory efficacy to enhance blood vessel formation, discovering therapies to improve angiogenesis is critical. An imidazolinone metabolite...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Huong, Koh, Jia Yi, Li, Hainan, Islas‐Robles, Argel, Meda Venkata, Sai Pranathi, Wang, Jie‐Mei, Monks, Terrence J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237315/
https://www.ncbi.nlm.nih.gov/pubmed/34105824
http://dx.doi.org/10.1096/fj.202002674RR
_version_ 1783714706302697472
author Nguyen, Huong
Koh, Jia Yi
Li, Hainan
Islas‐Robles, Argel
Meda Venkata, Sai Pranathi
Wang, Jie‐Mei
Monks, Terrence J.
author_facet Nguyen, Huong
Koh, Jia Yi
Li, Hainan
Islas‐Robles, Argel
Meda Venkata, Sai Pranathi
Wang, Jie‐Mei
Monks, Terrence J.
author_sort Nguyen, Huong
collection PubMed
description Peripheral arterial disease (PAD) is one of the major complications of diabetes due to an impairment in angiogenesis. Since there is currently no drug with satisfactory efficacy to enhance blood vessel formation, discovering therapies to improve angiogenesis is critical. An imidazolinone metabolite of the metformin‐methylglyoxal scavenging reaction, (E)‐1,1‐dimethyl‐2‐(5‐methyl‐4‐oxo‐4,5‐dihydro‐1H‐imidazol‐2‐yl) guanidine (IMZ), was recently characterized and identified in the urine of type‐2 diabetic patients. Here, we report the pro‐angiogenesis effect of IMZ (increased aortic sprouting, cell migration, network formation, and upregulated multiple pro‐angiogenic factors) in human umbilical vein endothelial cells. Using genetic and pharmacological approaches, we showed that IMZ augmented angiogenesis by activating the endothelial nitric oxide synthase (eNOS)/hypoxia‐inducible factor‐1 alpha (HIF‐1α) pathway. Furthermore, IMZ significantly promoted capillary density in the in vivo Matrigel plug angiogenesis model. Finally, the role of IMZ in post‐ischemic angiogenesis was examined in a chronic hyperglycemia mouse model subjected to hind limb ischemia. We observed improved blood perfusion, increased capillary density, and reduced tissue necrosis in mice receiving IMZ compared to control mice. Our data demonstrate the pro‐angiogenic effects of IMZ, its underlying mechanism, and provides a structural basis for the development of potential pro‐angiogenic agents for the treatment of PAD.
format Online
Article
Text
id pubmed-8237315
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82373152021-07-01 A novel imidazolinone metformin‐methylglyoxal metabolite promotes endothelial cell angiogenesis via the eNOS/HIF‐1α pathway Nguyen, Huong Koh, Jia Yi Li, Hainan Islas‐Robles, Argel Meda Venkata, Sai Pranathi Wang, Jie‐Mei Monks, Terrence J. FASEB J Research Articles Peripheral arterial disease (PAD) is one of the major complications of diabetes due to an impairment in angiogenesis. Since there is currently no drug with satisfactory efficacy to enhance blood vessel formation, discovering therapies to improve angiogenesis is critical. An imidazolinone metabolite of the metformin‐methylglyoxal scavenging reaction, (E)‐1,1‐dimethyl‐2‐(5‐methyl‐4‐oxo‐4,5‐dihydro‐1H‐imidazol‐2‐yl) guanidine (IMZ), was recently characterized and identified in the urine of type‐2 diabetic patients. Here, we report the pro‐angiogenesis effect of IMZ (increased aortic sprouting, cell migration, network formation, and upregulated multiple pro‐angiogenic factors) in human umbilical vein endothelial cells. Using genetic and pharmacological approaches, we showed that IMZ augmented angiogenesis by activating the endothelial nitric oxide synthase (eNOS)/hypoxia‐inducible factor‐1 alpha (HIF‐1α) pathway. Furthermore, IMZ significantly promoted capillary density in the in vivo Matrigel plug angiogenesis model. Finally, the role of IMZ in post‐ischemic angiogenesis was examined in a chronic hyperglycemia mouse model subjected to hind limb ischemia. We observed improved blood perfusion, increased capillary density, and reduced tissue necrosis in mice receiving IMZ compared to control mice. Our data demonstrate the pro‐angiogenic effects of IMZ, its underlying mechanism, and provides a structural basis for the development of potential pro‐angiogenic agents for the treatment of PAD. John Wiley and Sons Inc. 2021-06-09 2021-07 /pmc/articles/PMC8237315/ /pubmed/34105824 http://dx.doi.org/10.1096/fj.202002674RR Text en © 2021 The Authors. The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Nguyen, Huong
Koh, Jia Yi
Li, Hainan
Islas‐Robles, Argel
Meda Venkata, Sai Pranathi
Wang, Jie‐Mei
Monks, Terrence J.
A novel imidazolinone metformin‐methylglyoxal metabolite promotes endothelial cell angiogenesis via the eNOS/HIF‐1α pathway
title A novel imidazolinone metformin‐methylglyoxal metabolite promotes endothelial cell angiogenesis via the eNOS/HIF‐1α pathway
title_full A novel imidazolinone metformin‐methylglyoxal metabolite promotes endothelial cell angiogenesis via the eNOS/HIF‐1α pathway
title_fullStr A novel imidazolinone metformin‐methylglyoxal metabolite promotes endothelial cell angiogenesis via the eNOS/HIF‐1α pathway
title_full_unstemmed A novel imidazolinone metformin‐methylglyoxal metabolite promotes endothelial cell angiogenesis via the eNOS/HIF‐1α pathway
title_short A novel imidazolinone metformin‐methylglyoxal metabolite promotes endothelial cell angiogenesis via the eNOS/HIF‐1α pathway
title_sort novel imidazolinone metformin‐methylglyoxal metabolite promotes endothelial cell angiogenesis via the enos/hif‐1α pathway
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237315/
https://www.ncbi.nlm.nih.gov/pubmed/34105824
http://dx.doi.org/10.1096/fj.202002674RR
work_keys_str_mv AT nguyenhuong anovelimidazolinonemetforminmethylglyoxalmetabolitepromotesendothelialcellangiogenesisviatheenoshif1apathway
AT kohjiayi anovelimidazolinonemetforminmethylglyoxalmetabolitepromotesendothelialcellangiogenesisviatheenoshif1apathway
AT lihainan anovelimidazolinonemetforminmethylglyoxalmetabolitepromotesendothelialcellangiogenesisviatheenoshif1apathway
AT islasroblesargel anovelimidazolinonemetforminmethylglyoxalmetabolitepromotesendothelialcellangiogenesisviatheenoshif1apathway
AT medavenkatasaipranathi anovelimidazolinonemetforminmethylglyoxalmetabolitepromotesendothelialcellangiogenesisviatheenoshif1apathway
AT wangjiemei anovelimidazolinonemetforminmethylglyoxalmetabolitepromotesendothelialcellangiogenesisviatheenoshif1apathway
AT monksterrencej anovelimidazolinonemetforminmethylglyoxalmetabolitepromotesendothelialcellangiogenesisviatheenoshif1apathway
AT nguyenhuong novelimidazolinonemetforminmethylglyoxalmetabolitepromotesendothelialcellangiogenesisviatheenoshif1apathway
AT kohjiayi novelimidazolinonemetforminmethylglyoxalmetabolitepromotesendothelialcellangiogenesisviatheenoshif1apathway
AT lihainan novelimidazolinonemetforminmethylglyoxalmetabolitepromotesendothelialcellangiogenesisviatheenoshif1apathway
AT islasroblesargel novelimidazolinonemetforminmethylglyoxalmetabolitepromotesendothelialcellangiogenesisviatheenoshif1apathway
AT medavenkatasaipranathi novelimidazolinonemetforminmethylglyoxalmetabolitepromotesendothelialcellangiogenesisviatheenoshif1apathway
AT wangjiemei novelimidazolinonemetforminmethylglyoxalmetabolitepromotesendothelialcellangiogenesisviatheenoshif1apathway
AT monksterrencej novelimidazolinonemetforminmethylglyoxalmetabolitepromotesendothelialcellangiogenesisviatheenoshif1apathway